OB/GYN Clinical Alert – January 1, 2010
January 1, 2010
View Issues
-
USPSTF Mammography Recommendations: Seeing Through the Screen
Based on results of two systematic evidence reviews, the USPSTF issued a revised statement regarding recommendations for breast cancer screening. -
Intravenous Nitroglycerin for External Cephalic Version
Three to 5% of patients at term will have breech presentations, and in most countries 90% of these patients will be delivered by Cesarean section. -
Update on Adhesions and Gynecologic Surgery
This statement from the practice committee of the American Society for Reproductive Medicine provides an update to what is known about pelvic adhesions and gynecologic surgery. -
Anti-angiogenesis Targeting Agents in Recurrent Ovarian Cancer: Now There Are Two?
Angiogenesis is an important process, which sustains ovarian cancer growth. Cediranib, a potent, oral tyrosine kinase inhibitor (TKI) of vascular endothelial growth factor receptor (VEGFR) 1, 2, and 3, and c-kit, has shown promise in other solid tumors, including non-small cell lung cancer. -
Pharmacology Watch: Niacin Beats Ezetimibe Head to Head
In this issue: Statin and niacin increase HDL-C, omeprazole reduces effectiveness of clopidogrel, darbe-poetin increases risk of stroke, statins decrease risk of gallstone disease, FDA Actions. -
Clinical Briefs in Primary Care supplement